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Purpose: Many tools exist for quantifying magnetic reso-
nance spectroscopy (MRS) data. Literature comparing them
is sparse but indicates potential methodological bias. We
benchmarkMRS analysis tools to elucidate this.
Methods: Four series of phantom experiments, including
both solutions and tissue-mimicking gels, with constant con-
centrations of NAA, Creatine, Glutamine and Glutamate,
and iteratively increased concentrations of GABA are per-
formed. MEGA-PRESS spectra are acquired and quantified
with several state-of-the-artMRS analysis tools (LCModel,
TARQUIN, JMRUI, GANNET) and in-house code (LWFIT).
GABA-to-NAA ratios for reported metabolite amplitudes
are compared to the ground truth of known concentration
ratios. Overall estimation accuracy is assessed by linear fits
of reported vs. actual ratios and coefficients of determina-
tion. Simulations further elucidate the experimental results.
Results: Significant differences in reported GABA-to-NAA
amplitude ratios are observed. TARQUIN consistently over-
estimates, while most tools underestimate ratios to varying
degrees compared to the ground truth. Underestimation
∗Equally contributing authors.
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due to reduced editing efficiency is predicted by simulations.
LCModel performs comparatively well for well-resolved so-
lution spectra but struggles for intentionally miscalibrated
spectra and gel spectramimicking in-vivo conditions. GAN-
NET shows better consistency and robustness to calibra-
tion errors but greater underestimation related to how the
3 ppmGABA peak is fitted. Surprisingly, simple peak integra-
tion withminimal pre-processing yields themost consistent
and accurate results compared to the ground truth.
Conclusions: Amethodological dependence is observed not
only in the quantification results for individual spectra, but
in GABA-to-NAA gradients across experimental series, sys-
tematic offsets and coefficients of determination.
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1 | INTRODUCTION
Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system,maintaining
the excitation–inhibition balance. Its prominent role in neurotransmission andmetabolism has led to extensive study
and a plethora of applications for its detection. Disruption of GABAergic processes has been observed in Schizophrenic
patients [22, 47, 53] and GABA receptor dysfunction has associations with epilepsy [18, 31]. GABA processes are
prominent in type I diabetes [49] and autism spectrum disorders [6]. GABA is also the subject of intense study by the
psychological community, with GABA levels influencing impulsivity [5, 9], drug addiction [7],
anxiety disorders [41] and depression [43]. However, despite its wide range of applications, there are many
challenges associated with its detection and quantification in-vivo. Themost common tool for non-invasive detection of
GABA in-vivo is magnetic resonance spectroscopy (MRS). However, as GABA exists in the brain in mmol concentrations
and relatively stronger signals from other metabolites present overlap with, and obscure, the GABA signal, GABA
becomes generally observable at clinically relevant magnetic field strengths only through the use of editedMRS [11, 24,
25, 27] or other specialised techniques, such as 2D J -spectroscopy [15].
The most commonly usedMRS pulse sequence to detect GABA at fields strength up to 3T is theMEGA-PRESS
sequence [23, 25, 37, 54], which uses the PRESS [4] localisation schemewith the addition of a pair of frequency selective
editing pulses, placed symmetrically about the second refocusing pulse. Two acquisitions — ‘edit on’ and ‘edit off’ —
are made, which differ only in the frequency of the editing pulses. The frequency is chosen to take advantage of the
J -evolution of the target metabolites, such that upon subtraction of the two acquisitions, only the resonances in the
edit bandwidth, and those coupled to them, remain. The widespread use of MRS, particularly editedMRS, has seen
the development of a range of software packages aimed at processing and quantification of the spectra [8, 28, 35, 36,
40, 52, 56]. Quantification ofMRS data is usually performed after pre-processing, which entails some combination of
apodization, frequency and phase calibration, macromolecular baseline subtraction and residual water signal removal.
Each stepmay be realised by a diverse array ofmethods, providingmany potential avenues of variation for the quantified
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signal. This effect is compounded by further differences in the quantification procedure. Themost common approach to
quantification is the generation of a set of basis spectra— via phantom scans or simulation— followed by the application
of a fitting algorithm to decompose theMRS signal into weighted combinations of the basis functions. However, the
basis functions and fit algorithms vary by analysis tool, which provides potential for methodological bias.
While it has been argued that different methods, suitably applied, exhibit similar variation and clinical observa-
tions [42, 44], it is acknowledged in the literature that there is procedural dependency in MRS analysis [14, 19, 34],
which provides a statistically significant variation in reportedmetabolite amplitudes or relative concentrations [3, 21].
The goal of this study is to assess the variation of quantification results obtained, and to generate benchmark data
sets for the purpose of assessing the performance of new and existing tools. Previous work in this area has utilised
either in-vivo data— for which there is usually no ground truth to evaluate the results — or simulated data sets, which
inevitably cannot capture all sources of experimental variation. For this study, a series of MRS data sets based on
calibrated phantoms were generated [45]. While the phantoms inevitably fail to capture all influences of the in-vivo
environment, they do allow the inclusion of many experimental factors, while still enabling a ground truth comparison
and some ability to control environmental factors expected to influence results, allowing elucidation of their effect.
Four series of phantom experiments were conducted. In each series, the concentrations of various metabolites
— creatine (Cr), N-acetyl-L-aspartic acid (NAA), glutamine (Gln) and glutamate (Glu) — are fixed at approximately in-
vivo levels, while the concentration of GABA is iteratively increased. MEGA-PRESS spectra are acquired for each
concentration step and the GABA-to-NAA ratios are calculated based onmetabolite amplitudes reported by different
popular MRS analysis software. NAA was chosen as a reference metabolite due to its prominence in-vivo and its
consistent presence in difference spectra, unlikeCr andwater, the signals ofwhich should be eliminated in the difference
spectra. The four series of experiments were designed to increase the complexity of the spectra, starting with pH and
temperature calibrated solutions containing onlyNAA,Cr andGABA (E1), addingGlu andGln to the solutions to increase
the complexity of the spectra (E3) and finally progressing to a series of gel phantoms to more closely mimic in-vivo
spectra (E4)1. To investigate the effect of calibration errors, a series of experiments with intentionally miscalibrated
solutions of NAA, Cr and GABA (E2) were also performed. The GABA-to-NAA ratios derived from the metabolite
amplitudes reported by different tools are plotted against the known concentration ratios, and data fitting using linear
regression is performed to extract the gradient, offset, and the coefficient of determination, R 2. In an ideal setting
we expect the ratio of themetabolite amplitudes to scale linearly (R 2 = 1) with the actual concentration ratio, with a
gradient of 1 and zero offset corresponding to perfect quantification of GABA relative to NAA.
2 | MATERIALS AND METHODS
Phantom preparation procedures, experimental setup and scan parameters, and details of the analysis are described.
2.1 | Phantom preparation
The phantom study consists of four series of experiments — E1, E2, E3 and E4 — where the GABA (CAS-20791)
concentration of a metabolite phantom is varied over multiple acquisitions using a fixedMRS protocol. The background
metabolites—NAA (CAS-997-55-7), Cr (CAS-6020-87-7), Glu (CAS-142-47-2) andGln (CAS-56-85-9)—aremaintained
at a fixed concentration for a given series, so that GABA gradients are purely a result of GABA concentration changes.
E1, E2 and E3were solution series, where the GABA concentration of a liquid phantomwas increased incrementally.
1E4 corresponds to E4a in full dataset released.
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(a) Solution phantom. (b) Spherical gel phantom.
F IGURE 1 Images of phantoms. The gel phantoms are approximately 5.8 cm in diameter and the diameter of the
flask is approximately 8.2 cm.
TABLE 1 Concentration information in units of mM = mmol/l. All series, except E2, are pH calibrated to 7.0 ± 0.2.
Series NAA Cr Glu Gln GABA
E1 15.00 8.00 0.00 0.00 0.00, 0.52, 1.04, 1.56, 2.07, 2.59, 3.10, 4.12, 6.15, 8.15, 10.12, 11.68
E2 15.00 8.00 0.00 0.00 0.00, 0.50, 1.00, 1.50, 2.00, 2.50, 3.00, 3.99, 4.98, 5.96, 6.95, 7.93, 8.90, 9.88, 11.81
E3 15.00 8.00 12.00 3.00 0.00, 1.00, 2.00, 3.00, 3.99, 4.98, 5.97, 6.95, 7.93, 8.91, 9.88, 10.85, 11.81, 12.77, 13.73
E4 15.00 8.00 12.00 3.00 0.00, 1.00, 2.00, 3.00, 4.00, 6.00, 8.00, 10.00
For series E4, several spherical gel phantoms were made with varying GABA concentration. The full concentration
information of the experimental series is listed in Table 1 and representative images of the phantoms are shown in
Figure 1. A detailed description of the phantom preparation is included in Appendix A.
2.2 | Scan Protocols andData Acquisition
AllMRS scans were conducted at Swansea University’s Clinical Imaging Facility using a Siemens 3TMagnetom Skyra.
The scanner roomwas temperature controlled to 20±0 6◦C. Signal acquisition was done using the built-in spine coils,
specifically the four channel spine coil element ‘SP2’. The spine coils provided the platform for themost reproducible
set-up and SP2 exhibited the highest SNR of the spine coil elements available. The phantom was aligned with this
element and raised to isocenter, using a cardboard phantom holder, to ensuremaximum field homogeneity for the scans.
Double-spin-echo fieldmaps were acquired for each phantom to assess the homogeneity andmanual shimming and
frequency calibration was performed to optimise the spectral width. Further manual calibration was performed to
adjust the TX reference voltage and suppression pulses.
A 20×20×20mm3 voxel at the isocenter of themagnetwas selected for single voxel spectroscopy. TheMEGA-PRESS
spectra were acquired using the SiemensWIPMEGA-PRESS pulse sequence with CHESSwater-suppression [30] with
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TR = 2000ms,TE = 68ms, N = 160 averages and a sampling frequency of 1250Hz, N = 2048 samples. Editing pulses
were applied at 1.9 ppmduring the on acquisition and 7.4 ppmduring the off acquisition. Spectrawithwater suppression
turned off were also acquired to calculate linewidth andwater suppression factors and for water referencing.
For each experiment, the raw data acquired, the single-average coil-combined spectra and combined average
edit-on, edit-off and difference spectra produced by the vendor-supplied spectroscopy software are available [45].
Non-water-suppressed spectra for Eddy current correction and internal water referencing were also acquired. For
the comparison of the different software packages only the combined-average edit-on, edit-off and difference spectra
produced by the vendor-supplied spectroscopy software in Siemens dicom (IMA) format were used, as this format
was universally supported by all the software packages evaluated, allowing amore encompassing cross-section of the
methods. The common input format also reduced the potential sources of variation to the fitting and quantification
procedure (see Appendix B.2 for further information).
2.3 | Analysis methods
Prior to quantification, the 2 ppmNAA andwater peaks in each spectrum are fitted by Lorentzians, fromwhich the the
position, full-width-half-maximum (FWHM) andmaximum signal amplitude of the resonances are obtained. The noise
floor was estimated by computation of the standard deviation, σ , of the signal in the region 8−9 ppm, observed to be
free of metabolite signal, then the signal-to-noise ratio (SNR) calculated: S2σ . Water suppression factors are estimated
by comparing the height and area of the water peak in the water unsuppressed andwater-suppressed spectra.
The analysis software considered in this study can be broadly separated into two categories: (i) basis set methods
(TARQUIN, JMRUI, LCModel), which attempt to fit the data using a set of simulated or experimentally obtained basis
spectra and (ii) peak fitting and integration tools (GANNET, LWFIT), which compute the area of peaks associated
with variousmetabolites. The basis set methods generally use a least-squares (LS) or non-linear least-squares (NLLS)
approach to fit spectral data. Each analysis tool returns a set of metabolite amplitudes that indicate the relative
contributions of variousmetabolites to the overall spectrum. As the absolute signal values are arbitrary and depend
on the scanner design, transmitter calibration, coils used and the phantom itself, we focus on quantifying the relative
contributions of different metabolites. To this end, themetabolite amplitudes reported by each tool are plotted vs. the
metabolite concentrations and linear fits minimising the least-squares error are performed using theMATLAB curve-
fitting toolbox, focusing in particular on the ratio of the GABA andNAA amplitudes vs. the corresponding concentration
ratios. Brief descriptions of each tool included in this study are given in Appendix C and readers are directed to the
referenced literature for further information.
2.4 | Simulations
To facilitate interpretation of the experimental results, simulations were performed to emulate the experimental setup,
modulating GABA concentration while maintaining a fixed concentration of other selectedmetabolites. MEGA-PRESS
simulations were performed using the FID-appliance (FID-A) [48], a simulation and data processing package forMRS.
MEGA-PRESS difference spectra were generated, mirroring the sequence parameters of the phantom study with a
finite-bandwidth editing pulse alternating between 1.9 ppm and 7.4 ppm at a field strength of 2.89Twith an acquisition
bandwidth of 1250Hz and two and four step phase cycling. Spectra were generated for GABA, Cr, NAA, Glu and
Gln. The difference spectra were combined according to the concentrations used in the phantom experiments. The
metabolite models simulated were derived from the work of Govindaraju et al. [10]. For GABA, there is a greater degree
of uncertainty [16] and basis sets were generated for three distinct models that have been popularised in the literature
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TABLE 2 Total variation (∆) and standard deviation (σ) of transmitter frequency ν in Hz and reference voltage TX in
Volt and linear gradient offsetsGx ,Gy ,Gz for the four experimental series.
∆ν σ(ν) ∆TX σ(TX) ∆Gx σ(Gx ) ∆Gy σ(Gy ) ∆Gz σ(Gz )
E1 22 6.02 13.4 4.41 37 9.25 92 33.13 19 7.03
E2 28 7.42 17.1 4.89 36 10.58 51 16 62 16.52
E3 3 0.77 0.8 0.32 10 3.20 37 7.25 85 28.25
E4 9 3.18 0.3 0.11 0 0 0 0 0 0
by Govindaraju et al. [10], Kaiser et al. [13] and Near et al. [29], respectively. Simulated series were tested with all three
GABAmodels to investigate any potential bias of our simulated data. For all simulated series, GABA concentrations
were varied between 1mMand 12mMat 1mM intervals and the combined spectra were analysed using our in-house
code.
3 | RESULTS AND ANALYSIS
We initially assess the quality of the spectra and experimental calibration, before presenting the quantification results
obtained and simulation results to help elucidate the experimental findings.
3.1 | Calibration and characterisation of spectra
The stability of the experimental setup over the course of an entire series of experiments was assessed by considering
the variation of core parameters such as transmitter voltage and frequency, shim gradients and water suppression
settings. Table 2 shows that a small adjustment made to the experimental procedure for E3 and E4 to avoid table
movements between successive scans significantly reduced adjustments of transmitter frequency, reference voltage
and linear gradient offsetsGx ,Gy ,Gz , although the results are within acceptable limits for all four experimental series.
The difference spectra are shown in Appendix B.1.
Table 3 gives the linewidths of the water and NAA peaks obtained from Lorentzian peak fits, indicative values
for the water suppression factors (WSF) and the SNR of the NAA peak. While the linewidths increase for the gel
phantoms as expected, the width of the NAA peak in the difference spectrum remains around 4Hz, suggesting good
field homogeneity and frequency stability over the duration of the experiments. SNRs over 200 for NAA in the solution
series and over 100 for the gel phantoms are also well within the acceptable range.
3.2 | Quantification
The quantification results obtained are summarised in Table 4. The results are reported as slope and intercept with 95%
confidence intervals and R 2 value of a linear fit of the GABA-to-NAA amplitude ratios versus the actual concentration
ratios. The amplitude ratios are also plotted against the knownexperimental concentration ratios in Figure 2a–Figure 2d.
For the tools reporting peak areas rather than amplitudes (GANNET, LWFIT) the area ratio was multiplied by 32 to
account for the protonweightings of the GABA andNAA peaks but no other adjustments weremade.
Figure 2b shows the GABA–to–NAA ratio for the pH calibrated solution series E1. Themost notable feature of this
series is that TARQUIN overestimates it by almost a factor of three. All other tools underestimate GABA to varying
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TABLE 3 Linewidths (mean/std over series in Hz) of H2Opeak in spectra acquired without water suppression (WS
OFF) and the EDITON/OFF spectra with water suppression, NAA peak for EDITON and difference (DIFF) spectra with
water suppression, as well as median water suppression factor (WSF) and SNR of NAA peak.
H2OWSOFF H2OEDITON H2OEDITOFF WSF NAA EDITOFF NAADIFF SNRNAA
E1 2.40 ± 0.67 2.10 ± 0.54 2.11 ± 0.55 1840 1.19 ± 0.31 1.19 ± 0.31 209.6
E2 3.04 ± 1.44 2.82 ± 1.03 2.82 ± 1.03 1873 1.84 ± 0.33 1.85 ± 0.33 223.0
E3 2.98 ± 0.90 4.16 ± 2.02 4.16 ± 2.01 665 1.97 ± 0.25 1.98 ± 0.25 222.0
E4 11.16 ± 3.19 12.42 ± 9.01 12.54 ± 8.91 478 4.20 ± 1.48 4.25 ± 1.55 109.7
degrees from less than a third (0.279) of the actual ratio for GANNET (without adjustments) to around two thirds
for LCM, JMRUI AQSES and LWFIT. The R 2 values of the linear fit also vary quite considerably between tools, with
the highest correlation (99.5%) observed for LCM, followed closely by LWFIT, and the lowest (65%) for JMRUI.While
intercepts of the linear fits for most tools are close to zero, both the AQSES andQUEST versions of JMRUI give a very
large offset of almost 0.5, which suggests that some signal unrelated to GABA is erroneously assigned to GABA. As both
fitting algorithms exhibit this problem, it can likely be attributed to the pre-processing or basis set.
Figure 2b shows the results for the intentionally miscalibrated solution series. Although R 2 drops only slightly,
LCM performs significantly worse, under-estimating the GABA-to-NAA ratio at around 24% of the expected value.
Given the pH dependent components of the NAA signal that will not be properly captured by the basis set spectra, it is
unsurprising that basis set quantificationmethods performworse. Surprisingly, however, both TARQUIN and JMRUI
give significantly more accurate results for this series, with slopes close to 1 and higher R 2 than for the pH-calibrated
series. For TARQUIN this may be a fortunate consequence of its previously observed tendency to overestimate GABA.
However, this does not explain the significant improvement seen for JMRUI. The accuracy of the quantification for
GANNET, while expected to be less sensitive to pH changes, also improves, although the substantial overlap in the
confidence intervals of the parameters suggests that the improvement may not be significant. LWFIT also appears to be
robust to the pH changes, with GABA gradient estimation exhibiting only amodest reduction, from 69% for E1 to 54%
for E2, while maintaining a high R 2 of 0.97, as expected for a tool that only uses the 2 ppmNAA and 3 ppmGABA peaks,
which are independent of pH.
Figure 2c shows the results for the pH-calibrated solutions with Glu and Gln. We observe underestimation of
the GABA-to-NAA ratio at about 30%of the expected value for GANNET (without adjustments), moremodest under-
estimation at around 60% for LCM and LWFIT, and a reduced degree of overestimation of the GABA-to-NAA ratio
at 185% for TARQUIN, largely mirroring the results for E1. The most pronounced change is for JMRUI. While both
fitting routines (QUEST and AQSES) resulted in underestimation of the GABA-to-NAA ratio in E1 at around 60%, both
now overestimate the GABA-to-NAA ratio at 140%. The large changes could be due to systematic misidentification of
Glu andGln in the difference spectrum, falsely attributing it to GABA orNAA. It is somewhat surprising to see larger
changes for basis set methods (except LCM) as basis functions should be able to separate individual components better
than peak-fitting approaches. The quality of the GABA-to-NAA fits is better across the board, with higher R 2 values and
less variation in R 2 for different tools, ranging from R 2 of 0.7 to 0.8 for JMRUI to R 2 values over 0.95 for GANNET, LCM
and LWFIT. The overall improvement in the quality of the linear fits is unlikely to be related to the introduction of Glu
and Gln, but could be due to a small change in the experimental procedure resulting in fewer and smaller adjustments in
transmitter settings and shim gradients between scans as illustrated in Table 2.
Figure 2d shows the results for the gel phantom series with Glu and Gln. The fit quality for the gel series is generally
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TABLE 4 Linear fit results for GABA-to-NAA ratios in all four experimental series. Reported are the gradient a and
intercept b of the linear fit with 95% confidence intervals and the coefficient of determination R 2 (to three significant
digits). Perfect quantification corresponds to a = 1, b = 0 and R 2 = 1. The percentage variation of reported amplitudes
for NAA, whose actual concentration is constant, is also given. The large % variation of NAA amplitudes reported by
TARQUIN for E1 is due to an unexplained rescaling of metabolite amplitudes between scans 10 and 11. The % variation
of NAA for scans 1 – 10 is 6.09%. There is no simple explanation for the large variation reported by TARQUIN for E4.
Series Analysis Tool Gradient a with 95%CI Intercept b with 95%CI R 2 NAA%
E1 TARQUIN 2.85 (2.41, 3.30) −0.116 (−0.271,0.0526) 0.946 38.2
JMRUI (AQSES) 0.665 (0.365,0.965) 0.475 (0.366,0.583) 0.684 3.86
JMRUI (QUEST) 0.572 (0.297,0.847) 0.484 (0.385,0.584) 0.656 4.03
LCM 0.625 (0.597,0.654) 0.0164 (0.00602,0.0267) 0.995 2.76
GANNET 3 0.279 (0.209,0.349) −0.0126 (−0.0381,0.0128) 0.875 3.39
LWFIT 0.689 (0.61,0.768) 0.00856 (−0.0201,0.0373) 0.951 2.61
LWFIT (RAWSMOOTH) 0.642 (0.582,0.701) 0.0188 (−0.0026,0.0402) 0.981 3.98
E2 TARQUIN 1.07 (0.869,1.27) 0.051 (−0.0261, 0.128) 0.903 2.87
JMRUI (AQSES) 1.01 (0.730,1.29) 0.271 (0.164,0.378) 0.811 4.95
JMRUI (QUEST) 1.06 (0.722,1.39) 0.279 (0.151,0.4071) 0.766 5.52
LCM 0.239 (0.207,0.271) 0.0131 (0.000679,0.0254) 0.947 4.33
GANNET 3 0.335 (0.304,0.366) −0.0216 (−0.0333,−0.00977) 0.975 2.85
LWFIT 0.535 (0.48,0.59) −0.00467 (−0.0164,0.0257) 0.969 4.22
LWFIT (RAWSMOOTH) 0.523 (0.402,0.644) 0.0328 (−0.0134,0.0790) 0.860 5.35
E3 TARQUIN 1.85 (1.72,1.97) −0.0462 (−0.116,0.0237) 0.987 5.55
JMRUI (AQSES) 1.40 (0.866,1.93) 0.208 (−0.0846,0.500) 0.712 3.59
JMRUI (QUEST) 1.415 (1.04,1.79) 0.231 (0.0251,0.436) 0.836 3.31
LCM 0.599 (0.552,0.645) −0.0444 (−0.07,0.0187) 0.983 3.77
GANNET 3 0.30 (0.256,0.343) −0.00856 (−0.0334,0.0153) 0.945 3.31
LWFIT 0.625 (0.562,0.687) 0.0299 (−0.00399,0.0637) 0.973 1.59
LWFIT (RAWSMOOTH) 0.613 (0.548,0.678) 0.0406 (0.0053,0.0758) 0.969 2.60
E4 TARQUIN 1.77 (−0.544,4.08) 0.131 (−0.695,0.957) 0.368 42.1
JMRUI (AQSES) 1.17 (0.154,2.18) 0.478 (0.116,0.840) 0.570 5.85
JMRUI (QUEST) 1.02 (0.184,2.22) 0.521 (−0.0915,0.950) 0.417 6.11
LCM 0.451 (0.217,0.685) 0.036 (−0.0476,0.12) 0.788 7.83
GANNET 3 0.255 (0.168,0.342) 0.043 (0.0119,0.0742) 0.896 2.82
LWFIT 0.585 (0.349,0.82) −0.0325 (−0.0517,0.117) 0.860 2.29
LWFIT (RAWSMOOTH) 0.607 (0.369,0.846) 0.0341 (−0.0512,0.119) 0.866 5.23
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(a) E1 phantom series results. (b) E2 phantom series results.
(c) E3 phantom series results. (d) E4 phantom series results.
F IGURE 2 GABA-to-NAA amplitude ratios reported by different tools vs. actual concentration ratio.
lower, as expected due to higher FWHMand lower SNR for tissue-mimicking gels, with the highest R 2 between 0.85
and 0.9 achieved for peak fitting and integrationmethods (GANNET, LWFIT). Among the basis set methods, LCM again
outperforms TARQUIN and JMRUI in terms of linearity with R 2 around 0.8 vs. 0.4 to 0.6 for TARQUIN and JMRUI.
TARQUIN again overestimates the GABA-to-NAA ratio at 177%, while LCM, GANNET and LWFIT underestimate the
GABA-to-NAA ratio ranging from 26% to 59%of the actual ratio (without adjustments for editing efficiency). While the
slope of the fit for JMRUI is close to 1, the large offset at around 0.5 and very low R 2 suggest that this is incidental and
not indicative of accurate quantification.
3.3 | Simulation results
The experimental quantification results can be partially explained by simulations. Figure 3a shows the GABA-to-NAA
amplitude ratio obtained by LWFIT vs. the actual GABA-to-NAA ratio for three series of simulated experiments. The
blue line corresponding to the GABA-to-NAA ratios forMEGA-PRESS spectra generated assuming ideal excitation and
refocusing pulses has a slope of 1.01, within 1% of the actual ratio, and an intercept of −0.05, which suggests a small
negative offset, and an R 2 value of 1.00 (up to 3 significant digits). This suggests that the ratio of the GABA andNAA
peak areas indeed scale linearly with the concentration ratio and the actual ratio is reproducedwith very high accuracy
by this method for the ideal spectra. However, for spectra simulated assuming finite-duration refocusing pulses with
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realistic pulse envelopes, the GABA-to-NAA ratio is only 84%of its actual value for the NAA-GABA-Cre series and 80%
whenGlu and Gln are added. There is also amarginal reduction in the negative offsets, while the linearity is maintained
with R 2 = 1.00 throughout. This suggests that imperfect refocusing pulses may be one reason for the underestimation
of GABA-to-NAA ratios.
Spatially resolved spectra further confirm this. Figure 3 shows the 3 ppmGABA peak for the edit-on, edit-off and
difference spectra as a function of position on a 2D grid. The difference spectra near the boundary of the selected
voxel indicate that the editing efficiency is significantly reduced. In an experimental setting the editing efficiencywill
be further reduced by imperfect slice profiles of the excitation pulses and other factors such as field inhomogeneity.
Assuming these issues lead to a further reduction of the editing efficiency by a factor of 0.84 and 0.80, respectively, the
simulations predict GABA-to-NAA ratios of 0.7 and 0.64 of the actual value for E1 and E3, respectively, which is very
close to the values obtained by LCM and LWFI— 0.689 and 0.625 for LWFIT for E1 and E3, respectively. It is reasonable
to assume greater underestimation for the intentionally miscalibrated series (E2) and the gel phantom series (E4), which
is the case for LWFIT (0.535 and 0.585) and LCM (0.239 and 0.451). Themuch larger underestimation error for LCM is
unsurprising as basis set algorithms aremore susceptible to pHmiscalibration, especially considering that NAA, our
reference compound, has several minor pH-dependent peaks.
For TARQUIN we observe a reasonably consistent pattern of over-estimation in that the GABA-to-NAA ratio
obtained for E1 (2.91) is larger than for E3 (1.85), which is in turn slightly larger than for E4 (1.77) and quite significantly
larger than for E2 (1.07). The tendency of TARQUIN to overestimate the GABA-to-NAA ratio could be due to an internal
calibration factor designed to adjust for underestimation due to experimental factors, in particular considering that
TARQUIN appears to give themost accurate results for the intentionally miscalibrated series E2. The relatively poor
performance of TARQUIN forMEGA-PRESS difference spectra could also be explained by its use of a pseudo-model
for the difference spectra, which changes the expected phase of the 2.0 ppmNAA peak and fits GABA as a series of
Lorentzians, unlike for non-edited spectra, for which it uses a fully simulated basis set.
The JMRUI results aremore difficult to interpret. The GABA-to-NAA ratios are underestimated (0.665 and 0.572)
for E1 but significantly overestimated (1.40 and 1.415) for E3. Combinedwith the low values of R 2 and the large constant
offsets, this suggests that there are problemswith the fitting or pre-processing of the spectra. The significant increase
of the GABA-to-NAA ratio for E3 compared to E1 suggests that some of the Glu and Gln signal may bemisidentified as
GABA. The large offsets suggest problemswith baseline fitting, or inaccuracies in the generated basis set.
The GANNET results also require further investigation. Although the R 2 values of the linear fits are comparable to
other tools, ranging from 0.875 to 0.975, the degree of underestimation of the GABA–to–NAA ratios reported at 0.279,
0.335, 0.30 and 0.255 is surprisingly large. For the quantification of in-vivo data, Gannet attempts to correct for editing
efficiency, explicitly assuming an efficiency of 50% for the 3 ppmGABA peak. This is somewhat lower than suggested by
our simulation results, but might be attributed to different simulation parameters. However, even applying this factor
to the GABA-to-NAA ratios reported in Table 4, an underestimation of the gradients is still observed. It is also surprising
that the best estimation results are obtained for the intentionally miscalibrated series E2. Further investigation and
comparison with LWFIT suggests that themain reason for the underestimation is the way the area of the GABA peak is
computed by fitting a Gaussian using the default fitting routine. The results can be improved under certain conditions
using GANNET’s PhantomFit routine, details of which are discussed in Appendix D.
As different simulators use different models for GABA, e.g., LCM supports the Govindaraju and Kaiser model, while
JMRUI uses its ownmodified version of the Govindaraju and Kaiser models, we also performed simulations to assess
model dependence. GABA spectra simulated using the Govindaraju, Kaiser andNearmodel, shown in Figure 4 show
clear differences especially in the structure of the 3 ppmGABA peak. For LWFIT the GABA-to-NAA ratios were 0.96,
1.00 and 1.00 for the Govindaraju, Kaiser andNearmodels, respectively, for the NAA/Cr/GABA series, and 0.93, 0.98
JENKINS ET AL. 11
Series Gradient fit (95%CI) Intercept (95%CI) R 2
Ideal 1.01 (1.00, 1.02) −0.050 (−0.055, −0.044) 1.00
Realistic 0.84 (0.83, 0.85) −0.045 (−0.048, −0.042) 1.00
Realistic & Glu+Gln 0.80 (0.80, 0.80) −0.029 (−0.032, −0.027) 1.00
(a) GABA quantification results (LWFIT) for series of simulated spectra and linear fit parameters with 95% confidence intervals.
(b) Edit on, edit off and difference spectra for GABA (Nearmodel). 2D simulations performed using FID-A on an 8 × 8 grid over a
5 cm × 5 cm region with a target excitation volume of 2 cm × 2 cm in the centre.
F IGURE 3 2D simulations indicate that shaped refocusing pulses tend to significantly reduce the GABA editing
efficiency near the boundary of the voxel, resulting in underestimation of GABA.
and 0.98, respectively, for the NAA/Cr/GABA/Glu/Gln series when ideal refocusing pulses were used in the simulations.
While the difference between themodels appears small in this analysis, especially between the Kaiser and Near models,
numerical integration is relatively insensitive to the effects of coupling as J -evolved peak variations tend to average out
over the integrationwindow. The differences will bemore significant for basis set fittingmethodswhere the J -evolution
is actively simulated. Generally, the Kaiser and the Near model appear to approximate the experimental spectra better
than the older Govindaraju model.
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(a) Govindaraju et al. (b) Kaiser et al. (c) Near et al.
F IGURE 4 Simulated GABA spectra for the threemodels considered. Kaiser et al. andNear et al.models differ only
in some couplings, whereas Govindaraju’s model produces a significantly different spectrum.
TABLE 5 Mean and standard deviation of the linear fit parameters a (gradient) and b (intercept) and R 2 reported by
different fitting tools and percentage variation (%) of the gradient over all series (std(a)/mean(a) × 100).
TARQUIN JMRUI AQSES JMRUIQUEST LCM GANNET LWFIT
a 1.88 ± 0.734 1.06 ± 0.308 1.02 ± 0.346 0.479 ± 0.177 0.292 ± 0.0338 0.608 ± 0.0650
b 0.0068 ± 0.106 0.358 ± 0.139 0.379 ± 0.145 0.0053 ± 0.0346 0.0000659 ± 0.0291 0.0189 ± 0.0143
R 2 0.801 ± 0.291 0.694 ± 0.0991 0.669 ± 0.184 0.928 ± 0.096 0.922 ± 0.0458 0.943 ± 0.0554
% 39.0 29.1 34.1 37.0 11.6 10.7
4 | DISCUSSION
The results presented illustrate some of the shortcomings of the commonly used analysis software used for edited
spectra. In terms of linearity, TARQUIN, GANNET and LCMperformwell for the calibrated solution series but produce
far more inconsistent results for the gel phantom spectra. This may be partly explained by the lower SNR and broader
peaks of the gel spectra although the FWHMand SNR for the latter are still well within the acceptable limits suggested
in a recent consensus paper [55]. As gel phantoms are tissue-mimicking [32] and the gel spectra resemble in-vivo spectra
quite closely, for which the tools are designed, this is concerning.
With the exception of TARQUIN, which consistently overestimates GABA-to-NAA ratios, the tools studied tend
to underestimate GABA-to-NAA ratios to varying degrees. Simulations suggest realistic refocusing pulses reduce the
editing efficiency and can lead to a reduction in reported GABA-to-NAA ratios of up to 20%. Including additional losses
in experiments due to line broadening as a result of imperfect shimming and imperfect excitation pulses with realistic
slice profiles could therefore explain the underestimation of GABA bymany of the tools discussed.
LCMwas one of the best performing tools for the calibrated solution series E1 and E3with the highest R 2 values
for the linear fits at 0.99. While still underestimating GABA-to-NAA ratios, the degree of underestimation is consistent
with the losses expected based on simulation results, and only slightly worse than the results for LWFIT. However,
LCM performs poorly for the intentionally miscalibrated solution series E2 and also struggles with the gel phantom
spectra, resulting in greater underestimation and lower R 2 compared to the simple peak-integrationmethod (LWFIT).
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This suggests that LCM is an excellent tool for well-calibrated spectra but may not be the best tool for more challenging
spectroscopic environments. This conflicts somewhat with the findings ofMarzola et al. [21], who report LCM as the
best tool for low SNR spectra. However, the discrepancymay be due to LCM’s baseline modelling procedure being more
relevant for the lipid quantification study ofMarzola et al. [21], its basis set fitting algorithm being particularly sensitive
to pHmiscalibration, and its baseline fitting algorithm performing especially poorly for gel phantoms.
Although JMRUI performed poorly in our study, the results present a useful insight into the effect of the fitting
algorithm on quantification, independent of pre-processing, as both of themain fitting algorithms, QUEST and AQSES,
use the same pre-processed spectra. While the differences in the results reported for both methods are negligible
for E2 and E3, they are on the order of 10 − 15% for E1 and E4, which suggests a potential for diverging quantification
results and the presence of a methodological bias, independent of pre-processing. Reproducibility of quantification
results and the validity of cross-study comparisons are also limited due to JMRUI’s significant user dependencewith
pre-processing, filtering and frequency and phase calibration all handledmanually by the user, and basis set simulations
subject to user-defined processing steps such as apodization. It is therefore possible that an experienced user could
have improved its performance by carefully optimising each processing step.
A surprising result is that LWFIT, a simple peak integration method, appears to give the most consistent results
across all series including for the gel spectra with R 2 values above 0.95 for the solution series and still among the
highest for the gel spectra. While peak integration still underestimates the true concentration ratios in many situations,
the estimates are more consistent and closer to the expected ratios than for any of the more sophisticated tools
covered. While perhaps not a viable option for the quantification of complex spectra produced by standard spectroscopy
sequences, simple methods such as this could be useful for the analysis of edited spectra, which are often simplified
significantly. The results also suggests that peak fitting and extensive pre-processing steps such as filtering and baseline
correctionmay actually be detrimental to the accuracy of GABA estimation, althoughmore work is needed to properly
substantiate this claim.
GANNET, the only non-basis set tool considered aside from our LWFIT code, performs worst in terms of the degree
of underestimation of GABA-to-NAA ratios ranging from 0.335 of the actual value for E2 to 0.255 for E4 — without
adjustments for editing efficiency—but has the lowest variation inGABA-to-NAA ratios (m) reportedwithσ(m)/ave(m)
of 11% (see Table 5). While its R 2 value for the calibrated solutions is lower than for LCM (0.875 vs. 0.995 for E1, 0.945 vs.
0.983 for E3), for example, it outperforms LCM for the gel phantoms (0.896 vs. 0.788 for E4) andmiscalibrated solution
series (0.975 vs. 0.947 for E2). The consistency of the underestimation is a testament to GANNET’s robustness, but the
accuracy of quantification in Gannet is dependent upon the correct modelling of edit efficiency. The underestimation of
the GABA-to-NAA ratio— even after correcting for edit efficiency— can be partly attributed to the Gaussianmodel
used by the standard fitting routine, and the results can be improved in some cases using GANNET’s phantom fit routine.
Overall the results suggest that peak integrationmethods aremore robust than basis set methods for editedMRS,
perhaps a consequence of the simplified spectral landscape, eliminating the requirement for basis set fitting. This in
agreement with the observations ofMarzola et al. [21], who also reported the robustness of thesemethods in-vitro but
note the poor performance of integrationmethods in-vivo. However, due to the absence of a ground truth the accuracy
of quantification is difficult to establish for in-vivo data.
5 | CONCLUSION
MEGA-PRESS spectra for carefully designed phantomswere analysed using different software tools commonly used in
the community to quantifyMRS data as well as our in-house code (LWFIT). Ratios of metabolite amplitudes, specifically
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GABA-to-NAA, were calculated and compared to the actual concentration ratios in the phantoms. Linear regression
fits of the reported vs. actual ratios were performed to assess the overall quality and accuracy of the quantification.
The results show that GABA-to-NAA ratios reported by different tools can differ substantially from each other and
the ground truth of known concentration ratios for the phantoms. Compared to the ground truth, most tools assessed
underestimate GABA-to-NAA ratios to varying degrees, although some such as TARQUIN consistently overestimated
GABA-to-NAA ratios.
The tendency to underestimate GABA relative to NAA for theMEGA-PRESS implementation used in our study was
consistent with simulations predicting underestimation due to reduced editing efficiency near voxel boundaries due to
imperfect refocusing pulses and slice profiles. The accuracy of GABA estimation results thereforemight be better for
other implementations of theMEGA editing scheme, e.g., using adiabatic refocusing pulses. It would be desirable to
repeat the calibrated phantom experiments for different sequences to identify the best-performing sequences and
protocol parameters.
Of the tools considered (excluding our LWFIT code), LCM provides more accurate estimation results for well-
resolved spectra but exhibits poor robustness to calibration errors and performs only moderately well for less well-
resolved gel phantom spectra, whichmore closely resemble typical in-vivo spectra. GANNET appears to be themost
robust tool considered, reporting themost consistent results across the experimental series, but it also exhibits the
largest degree of underestimation of GABA-to-NAA ratios, some of which persists evenwhen adjustments for editing
efficiency aremade. In some cases fitting results substantially improved by replacing the Gaussian fit by amodel that
better captured the pseudo-triplet nature of the GABA peak.
The systematic errors observed require further study to elucidate the precise nature of the variation and this work
highlights the need for standardisation of existingmethods and the development of new approaches to quantification of
MRS data.
Themethodological dependence of the quantification results observed also suggests that care must be taken when
comparing results across studies, where analysis pipelines may differ and standardisation is desirable where possible.
Furthermore, themethodological dependence is not restricted to instantaneousmeasurements of GABA, but is in fact
found to propagate into reported changes in concentration, with tools presenting a range of GABA-to-NAA gradients.
This finding is of great relevance to clinical studies, with our results suggesting that reported differences between
normative and disease state GABAmeasurements will also be influenced by the choice of analysis method.
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SUPPLEMENTARY MATER IAL
A | DETAILED DESCRIPTION OF PHANTOM PREPARATION
The solution series were prepared by dissolving the required concentrations of metabolites to remain constant in
de-ionised water to create a base solution. To avoid variations in these backgroundmetabolites over a series of scans,
a small amount of this base solution was removed using a syringe and GABAwas added to prepare a solution with a
GABA concentration of 1mg/ml and the same concentration of the base metabolites. 290ml of the GABA-free base
solution were transferred to a round bottom glass flask, filling it to the neck. To vary the GABA concentration between
scans, a small amount of the solution was removed from the flask with a syringe and replaced by the same volume
of the concentrated GABA solution. The amount of solution replaced in each step varied, depending on the desired
GABA concentration change, but was generally between 0.5ml and 2ml. This procedure was repeated several times,
iterating GABA to a relatively high concentration. The same scan protocols were applied for each concentration
step. This procedure limits experimental errors solely to the GABA concentration. Where stated, pHwasmonitored
between scans and adjustmentsweremade using a 36%hydrochloric acid (CAS-7647-01-0) solution and a 3.99%sodium
hydroxide solution (CAS-1310-73-2) to maintain a pH of 7.2 ± 0.2. The amounts of HCl or NaOH added after the initial
pH calibration of the base solution weremarginal (≤ 1ml for the 290ml flask) and any dilution of the overall solution
was therefore deemed negligible. E2was one exception, where pHwas intentionally mis-calibrated to investigate the
effect this had on the various quantification procedures. The final pH of E2wasmeasured to be 3.0 ± 0.2.
For the gel series, the phantoms were made in advance of scanning. 800ml of a base solution of Glu, Gln, NAA
and Cr was prepared and divided into eight 100ml portions. Different amounts of GABAwere added to each solution
and pH calibration was performed as above. Finally, 1 g of agar (CAS-9002-18-0) 2 was added as gelling agent. The
mixtures were then heated to 90 ◦C to 100 ◦Cwhile being stirred until the agar had fully dissolved. A small hole (< 2mm
diameter) was created in a spherical plastic mould using a plastic welding tool and the solutions were injected via a
syringe. The arrangement was then allowed to cool over night. Once solidified, the gels were examined and the opening
was sealed using a small amount of silicone sealant. Spherically-shaped phantomswere deemed themost suitable to
reducemagnetic susceptibility-induced field inhomogeneity andminimise the spectral linewidth.
The accuracy of the scale used for mass measurements is 1mg and the graduated cylinders used for the volume
measurements have an accuracy of 1ml. Assuming negligible errors in the manufacturer’s stated molar masses, the
uncertainty ∆c in the molar concentration c = mMV , wherem is the mass in grams,M is the molar mass of the solute
andV is the volume of the solvent, is ∆cc =
√[
∆m
m
]2
+
[
∆V
V
]2. Assuming (generously) an uncertainty of 2% for the
massmeasurements and 1% for the volumemeasurement, the uncertainty in the concentrations of basemetabolites is
estimated to be less than 3%. The uncertainty in the amount of solution added or removed from the flask in each step
via 5ml syringes is slightly higher and could be up to 10%, assuming an uncertainty of 0.1ml per 1ml to account for slight
misreadings of the plunger position and tiny air pockets within the syringe.
B | SPECTROSCOPY DATA ACQUIRED
B.1 | Difference spectra
The difference spectra acquired for series E2, E3 and E4 shown in Figure 5, are consistent with the structure predicted
by simulations and closely resemble the spectra predicted for the Kaiser/Near model. The expected pseudo-triplet
2Food-grade agar was sourced for this study
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(a) Spectra for series E3 (b) Spectra for series E2
(c) Spectra for gel phantom series E4 (d) in-vivo brain spectra for comparison
F IGURE 5 Difference spectra aligned to 2.01 ppmNAA peakwith 3 ppmGABA peak shaded. Vertically offset
spectra correspond to increasing concentrations of GABA for phantoms and different volunteers for in-vivo example.
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structure, clearly visible for the well-calibrated solution series E3, is still discernible in the gel phantom spectra E4 but
the lineshape is broader andmore variable, while it is largely obscured for the intentionally miscalibrated series E2.
Spectra for E1 are similar to E3 and have been omitted. A number of in-vivo spectra acquired using the same sequence
and protocol on the same scanner (2 × 2 × 2cm3 voxel in the prefrontal cortex of healthy volunteers) shows slightly
broader peaks but a similar structure to our phantom spectra, especially our gel phantom spectra.
B.2 | Raw data vs. vendor-supplied dicoms
For the purpose of this paper, the combined channel and average spectra generated by vendor-supplied spectroscopy
software in dicom format were used. Although this is advantageous for consistency and the spectra are generally
suitable, some of spectra generated by the vendor-supplied software are reconstructed with relative phase errors,
resulting in invalid difference spectra upon subtraction. Our own raw-data reconstruction was able to rectify this issue,
but for compatibility with the various tools, the dicomswere preferred. All data included in the comparative analysis
were screened for this problem to ensure valid difference spectra were included.
C | OVERVIEW OF ANALYSIS SOFTWARE
C.1 | LWFIT
Our in-house code, LWFIT, written inMATLAB, aligns the edit-off and difference spectra so that themain NAA peak
is precisely at 2.01 ppm and then calculates the areas for the NAA (1.91 ppm to 2.11 ppm, difference), Cr (2.90 ppm to
3.10 ppm, edit-off) and GABA (2.90 ppm to 3.12 ppm, difference) peaks, as well the two main peaks associated with
Glu andGln, GLX1 (2.25 ppm to 2.45 ppm, difference) and GLX2 (3.65 ppm to 3.85 ppm, difference), using the real part
of the spectra. This is done by numerical integration using piecewise-linear functions over the indicated fixed ppm
ranges, selected to minimise contamination from other signals. Lorentzian, Gaussian and spline fitting and several
baseline fitting and filtering methods were explored but initial testing indicated that numerical integration with minimal
pre-processing yielded themore accurate estimation results compared to the ground truth. While more aggressive
noise filters aesthetically improve the quality of the spectra, their application tends to increase the underestimation of
GABA, especially for weak signals, suggesting that filtering eliminates some of the GABA signal present in the data [12].
For this work, only zero-filling (N = 4096 points) and a frequency shift to align theNAApeak in the spectrum to 2.01 ppm
are performed. A Hanning filter of length 3500 is (optionally) applied to spectra computed directly from raw data
(Raw Smooth version). No additional filters are applied to the coil-and-channel combined spectra produced by the
vendor-supplied software. The results are reported as peak areas and ratios.
C.2 | TARQUIN
Totally Automatic Robust Quantitation in NMR (TARQUIN) [40, 56] is a cross platform, time domain basis set analysis
tool. TARQUIN is an open source software package written in C++, complete with a GUI (Graphical User Interface)
and a built-in NMR simulator. TARQUIN uses a Lawson-Hanson non-negative least-squares algorithm [17] with a basis
set of pre-simulated spectra, which can be provided by the user. Residual water removal is performed using HSVD
(Hankel Singular Value Decomposition) [1, 2] and automated phase and frequency correction is applied. TARQUIN does
not perform a full MEGA-PRESS simulation, but rather models the expected signal and adjusts its phase correction
procedures to accommodate the negative NAA peak. Frequency calibration is made relative to NAA. Results are
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reported as fit amplitudes. For this paper, TARQUIN version 4.3.11with its internalMEGA-PRESS basis set was used.
C.3 | JMRUI
JMRUI [28, 52] is proprietary software distributed under its own license terms andmade freely available to registered
users for non-commercial use. It has a large suite of pre-processing, analysis and simulation options. Macromolecular
baselines are fitted non-parametrically using penalised splines. For this study, two basis set methods were used to
quantify the spectra. The first, quantitation based on semi-parametric quantum estimation (QUEST) [38, 39], is a
time-domain fitting tool, which includes a semi-parametric approach to handle spurious signals resulting frommacro
molecules and lipids. The secondmethod, automated quantitation of short echo timeMRS spectra (AQSES) [33], uses
amodified VARPRO variable projection NLLS algorithm [46], with imposes prior knowledge in the form of upper and
lower bounds on the nonlinear parameters. For this study JMRUI version 6.0 beta was used. MEGA-PRESS basis
sets were generated using NMR-SCOPE-B [50, 51] by defining a singleMEGA-PRESS pulse sequencewith sequence
parameters matching our experimental protocol. Two basis sets for GABA/Cr/NAA andGABA/Cr/NAA/Glu/Gln were
generated. Manual frequency and phase calibration and apodization were performed on the input spectra and fitting
was applied using this common input. Results reported are the fit amplitudes.
C.4 | LCModel
LCModel (LCM) [35, 36] is a commercial, Linux-based closed-sourceMRS analysis tool that can be used with its internal
in-vitro basis set or any arbitrary basis set specified by the user. The baseline signal resulting frommacromolecules
is established using spline fits. Fitting is attempted using a Gauss-Newton non-linear least-squares algorithm with
Marquardtmodification [20] with additional terms forT2 , spectral shift and field inhomogeneities. For this paper version
6.3-1L and the Purcell lab basis set [26] recommended by LCM’s creators were used.
C.5 | GANNET
GABA-MRS analysis tool (GANNET) [8] is an open-source automatedMATLAB-based analysis tool, specifically designed
for automated processing of 3TGABAMEGA-PRESS data. GANNET consists of two separatemodules, GANNETLoad
and GANNETFit. The first module receives time-domain data, performs channel combination, adds line broadening,
frequency and phase corrections, outlier rejection and time averaging. The output structure is then analysed by the
fitting module. Fitting is performed using non-linear least-squares algorithms (lsqcurvefit and nlinfi) and is based
on a five parameter Gaussian model to estimate the 3 ppmGABA signal in the difference spectrum, a six parameter
Lorentzian model to estimate the 3 ppm Cr signal in the off spectrum and, if appropriate, a six parameter Gaussian-
Lorentzianmodel to fit the unsuppressedwater signal. Quantitative results are reported as integral ratios of GABA to
Cr and a concentration relative to water, NAA or Glx (Glu and Gln combined). While GANNET attempts to remove user
interaction from the analysis procedure, it allows user modification of the code and adjustment of the pre-initialisation
script is encouraged depending on setup. For this paper GANNET version 3.0 was used and the pre-initialisation script
was adjusted to account for the fact that the phantoms spectra were acquired at room temperature.
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F IGURE 6 Example of 3 ppmGABA peak for the calibrated series E1 (left) and intentionally miscalibrated series E2
(right) with GANNETGaussian fit (red) and residuals, showing poor fit and large residuals for E1, where the triplet
structure is clearly visible, but much better fit for E2, where the triplet structure is obscured due to line broadening.
D | GANNET FIT VS GANNET PHANTOM FIT
As noted in the discussion, GANNET’s standard fitting routine underestimates GABA–to-NAA ratios more significantly
than other tools, and a degree of underestimation persists even after adjusting for editing efficiency. For comparison,
without adjustments for editing efficiency, LWFIT, a basic peak integrationmethod, estimates GABA–to–NAA ratios
at about 60% of the actual value, close to the value expected considering the editing efficiency suggested by our
simulations, while the GANNET estimates are generally well below 50%, so still correspond to underestimation even
when a correction factor of 2 is applied.
Underestimatation of GABA is more probable in view of Figure 6 showing that the pseudo-triplet structure of the
GABA peak for a well-resolved phantom spectrum (E1) is poorly fit by a Gaussian, leading to a large residual, while the
structure of the GABA peak in the experimental spectrum for the intentionally miscalibrated series E2 is obscured
and the peak appears more Gaussian, resulting in a better fit for the Gaussianmodel. The intentional miscalibration
has a similar effect to introducing field inhomogeneity, resulting in line broadening. To deal with non-Gaussian GABA
peaks GANNET has an alternative fitting routine GannetFitPhantom, which attempts to fit pseudo-triplet GABA peaks
by a triplet of Lorenzians. While our primary aim was to benchmark the routines commonly used for quantification
of in-vivo spectra, we also quantified each of the spectra using both the standard (Gaussian) fitting routine and the
phantom-fitting routine.
Figure 7 shows the phantom fit routine indeed performs somewhat better for series E1 and E3, while the regular
Gaussian fitting routine performs slightly better for E2, as expected. The differences are not very large, however. Sur-
prisingly, the phantom fit routine appears to have amore substantial advantage for the tissue-mimicking gel phantoms,
for which we expected the Gaussian fit routine typically used for in-vivo spectra to have an edge.
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(a) Series E1 (b) Series E2
(c) Series E3 (d) Series E4
F IGURE 7 Comparison of GannetPhantomFit and the regular GannetFit routine
